Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis
- PMID: 36450980
- DOI: 10.1038/s41586-022-05487-2
Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis
Retraction in
-
Retraction Note: Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.Nature. 2025 Aug;644(8075):290. doi: 10.1038/s41586-025-09015-w. Nature. 2025. PMID: 40634621 No abstract available.
Abstract
Medulloblastoma (MB) is the most common malignant childhood brain tumour1,2, yet the origin of the most aggressive subgroup-3 form remains elusive, impeding development of effective targeted treatments. Previous analyses of mouse cerebella3-5 have not fully defined the compositional heterogeneity of MBs. Here we undertook single-cell profiling of freshly isolated human fetal cerebella to establish a reference map delineating hierarchical cellular states in MBs. We identified a unique transitional cerebellar progenitor connecting neural stem cells to neuronal lineages in developing fetal cerebella. Intersectional analysis revealed that the transitional progenitors were enriched in aggressive MB subgroups, including group 3 and metastatic tumours. Single-cell multi-omics revealed underlying regulatory networks in the transitional progenitor populations, including transcriptional determinants HNRNPH1 and SOX11, which are correlated with clinical prognosis in group 3 MBs. Genomic and Hi-C profiling identified de novo long-range chromatin loops juxtaposing HNRNPH1/SOX11-targeted super-enhancers to cis-regulatory elements of MYC, an oncogenic driver for group 3 MBs. Targeting the transitional progenitor regulators inhibited MYC expression and MYC-driven group 3 MB growth. Our integrated single-cell atlases of human fetal cerebella and MBs show potential cell populations predisposed to transformation and regulatory circuitries underlying tumour cell states and oncogenesis, highlighting hitherto unrecognized transitional progenitor intermediates predictive of disease prognosis and potential therapeutic vulnerabilities.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Comment in
-
Lack of evidence for the transitional cerebellar progenitor.Nature. 2025 Jul;643(8071):E1-E8. doi: 10.1038/s41586-025-09247-w. Epub 2025 Jul 9. Nature. 2025. PMID: 40634749 No abstract available.
References
-
- Wang, J., Garancher, A., Ramaswamy, V. & Wechsler-Reya, R. J. Medulloblastoma: from molecular subgroups to molecular targeted therapies. Annu. Rev. Neurosci. 41, 207–232 (2018). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous